Parsey Merdad
SEC insider (Form 3/4/5 filer). CIK 0001792150. Director at ArriVent BioPharma, Inc. (AVBP) and 2 other issuers. 23 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in WALTHAM, MA.
Companies Parsey Merdad has filed insider reports for
- ArriVent BioPharma, Inc. (AVBP): Director
- ARDELYX, INC. (ARDX): Director
- GILEAD SCIENCES, INC. (GILD): Officer, Chief Medical Officer
Parsey Merdad
CIK: 0001792150
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Jun 18, 2026AVBP
ArriVent BioPharma, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
13.6K shares- - Jun 16, 2026ARDX
ARDELYX, INC.
AwardDirect26.5K shares- - Jun 18, 2025ARDX
ARDELYX, INC.
AwardDirect15.2K shares- - Jun 18, 2025AVBP
ArriVent BioPharma, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
15.5K shares- - Apr 28, 2025ARDX
ARDELYX, INC.
AwardDirect42.1K shares- - Apr 28, 2025AVBP
ArriVent BioPharma, Inc.
AwardDirectStock Option (right to buy)
28.3K shares- - Dec 10, 2024GILD
GILEAD SCIENCES, INC.
ExerciseDirect3.8K shares- - Dec 10, 2024GILD
GILEAD SCIENCES, INC.
Tax PaymentDirect1.8K shares at avg. $92.34$164K - Nov 27, 2024GILD
GILEAD SCIENCES, INC.
SaleDirect88.1K shares at avg. $92.00$8.1M - Nov 27, 2024GILD
GILEAD SCIENCES, INC.
SaleDirect10.4K shares at avg. $92.00$957K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  AVBP ArriVent BioPharma, Inc. | Award Non-Qualified Stock Option (right to buy) | 13,562 | - | - | Direct |
| Jun 16, 2026 |  ARDX ARDELYX, INC. | Award | 26,455 | - | $0 | Direct |
| Jun 18, 2025 | ARDX ARDELYX, INC. | Award | 15,235 | - | - | Direct |
| Jun 18, 2025 | AVBP ArriVent BioPharma, Inc. | Award Non-Qualified Stock Option (right to buy) | 15,502 | - | - | Direct |
| Apr 28, 2025 | ARDX ARDELYX, INC. | Award | 42,056 | - | - | Direct |
| Apr 28, 2025 | AVBP ArriVent BioPharma, Inc. | Award Stock Option (right to buy) | 28,346 | - | - | Direct |
| Dec 10, 2024 |  GILD GILEAD SCIENCES, INC. | Exercise | 3,820 | - | $0 | Direct |
| Dec 10, 2024 | GILD GILEAD SCIENCES, INC. | Tax Payment | 1,771 | $92.34 | $163,534 | Direct |
| Nov 27, 2024 | GILD GILEAD SCIENCES, INC. | Sale | 88,119 | $92.00 | $8,106,948 | Direct |
| Nov 27, 2024 | GILD GILEAD SCIENCES, INC. | Sale | 10,399 | $92.00 | $956,708 | Direct |
1-10 of 23 transactions